Immediate Impact
4 from Science/Nature 60 standout
Citing Papers
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
2022 Standout
Gliflozins in the Management of Cardiovascular Disease
2022 Standout
Works of A. Starke being referenced
Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.
1987
Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes.
1985
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Starke | 478 | 134 | 323 | 136 | 29 | 872 | |
| Monica Locatelli | 211 | 318 | 195 | 103 | 33 | 1.1k | |
| Moufida Ben Nasr | 444 | 279 | 461 | 87 | 35 | 1.1k | |
| A. Pacifico | 193 | 198 | 245 | 204 | 29 | 818 | |
| D. R. Cullen | 581 | 131 | 375 | 215 | 36 | 1.2k | |
| Karen O. Badellino | 345 | 142 | 331 | 144 | 22 | 951 | |
| Yukihiro Nagai | 197 | 224 | 210 | 138 | 49 | 783 | |
| R Mahler | 217 | 213 | 196 | 145 | 38 | 790 | |
| Mayumi Yano | 358 | 221 | 235 | 101 | 43 | 872 | |
| Gábor Firneisz | 271 | 234 | 183 | 233 | 46 | 949 | |
| Hasan Altunbaş | 498 | 197 | 335 | 123 | 49 | 1.0k |
All Works
Loading papers...